Observational Study of Vision Improvement in Late Stage Dry AMD Patients

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

August 14, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Dry Age-related Macular Degeneration
Interventions
DEVICE

Corneal treatment by a low vision aid device

Near infrared light is used to irradiate the cornea to change the modulus of small volumes of anterior stroma. The change of modulus produces a change of corneal stiffness and shape that modifies the distribution of light onto the retina. Light rays are redirected from dysfunctional areas of the retina that have been damaged by age-related macular degeneration (AMD) to functional areas of the retina, thereby improving patient vision.

Trial Locations (1)

M5R 1A9

Bochner Eye Institute, Toronto

Sponsors
All Listed Sponsors
collaborator

Bochner Eye Institute

UNKNOWN

lead

Optimal Acuity Corporation

INDUSTRY

NCT04349254 - Observational Study of Vision Improvement in Late Stage Dry AMD Patients | Biotech Hunter | Biotech Hunter